指南与共识青光眼

欧洲青光眼学会——青光眼手术创新指南

European Glaucoma Society - A guide on surgical innovation for glaucoma.
指南 / 共识 · Br J Ophthalmol · 2023-12-21

欧洲青光眼学会发布青光眼手术创新指南,回顾现有证据并聚焦近期创新与新型装置,同时为未来青光眼手术创新研究设定手术设计与报告标准。指南还针对证据不足但已在临床使用的新术式提供临床建议,强调个体化决策与高质量证据对创新落地的重要性。

要点

  • 指南旨在综述青光眼手术尤其是近期创新与新型装置的现有证据,并为未来研究设定设计与报告标准。
  • 对小梁切除术联合抗代谢药物这一传统金标准及引流管手术之后出现的新术式,指南在证据不足时提供临床建议。
  • 指南强调个体化方法,不存在适用于所有情况和所有患者的统一答案。

核心结论

  • 指南旨在回答新型青光眼手术是否更安全、疗效更好或相当、是替代还是补充传统手术以及如何为患者选择术式等关键问题。
  • 指南强调需通过临床方法和可能的算法在个体层面达成决策,不存在适用于所有情况和所有患者的统一答案。
  • 将创新转化为成功实施至关重要,需要高质量证据以确保对医疗保健产生积极影响。

研究设计与样本

  • 本文件为欧洲青光眼学会(EGS)发布的指南,由EGS组织制定,旨在为临床医生提供青光眼手术领域的指导。
  • 指南概述现有青光眼手术证据,重点聚焦近期创新与新型装置,并为未来青光眼手术创新研究设定手术设计与报告标准。
  • 指南还针对证据不足但已在临床使用的新术式提供临床建议。

主要发现

  • 数十年来青光眼手术由小梁切除术联合抗代谢药物这一普遍金标准主导,引流管手术作为传统青光眼手术的补充进入临床。
  • 近期随着微创青光眼手术(MIGS)的出现,青光眼手术环境正在发生变化。
  • 新青光眼技术和装置旨在提供比传统手术更安全的手术,但更安全是否伴随更好、相当或更差的疗效尚需证据支持。

关键数值与推荐

  • 指南使用创新、教育、沟通、实施四个词强调一个连续统一体。
  • EGS的愿景是在可负担的医疗体系内为青光眼患者提供最佳福祉和最小青光眼所致视觉残疾。

临床怎么用

  • 指南旨在帮助临床医生为患者做出适当决策,并为研究人员提供框架和指导以改善未来研究的证据质量。
  • 临床医生需通过临床方法和可能的算法在个体层面达成答案和决策,个体化方法必不可少。

局限性

  • 手术研究设计尤为困难,因为手术本身存在许多细微变异,结局涉及多种因素。
  • 需要仔细定义与研究问题相关且与未来临床转化相关的结局。
  • 指南针对证据不足但已在临床使用的新术式提供临床建议。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PROLOGUE: Glaucoma surgery has been, for many decades now, dominated by the universal gold standard which is trabeculectomy augmented with antimetabolites. Tubes also came into the scene to complement what we use to call conventional or traditional glaucoma surgery. More recently we experienced a changing glaucoma surgery environment with the "advent" of what we have become used to calling Minimally Invasive Glaucoma Surgery (MIGS). What is the unmet need, what is the gap that these newcomers aim to fill? Hippocrates taught us "bring benefit, not harm" and new glaucoma techniques and devices aim to provide safer surgery compared to conventional surgery. For the patient, but also for the clinician, safety is important. Is more safety achieved with new glaucoma surgery and, if so, is it associated with better, equivalent, or worse efficacy? Is new glaucoma surgery intended to replace conventional surgery or to complement it as an 'add-on' to what clinicians already have in their hands to manage glaucoma? Which surgery should be chosen for which patient? What are the options? Are they equivalent? These are too many questions for the clinician! What are the answers to the questions? What is the evidence to support answers? Do we need more evidence and how can we produce high-quality evidence? This EGS Guide explores the changing and challenging glaucoma surgery environment aiming to provide answers to these questions. The EGS uses four words to highlight a continuum: Innovation, Education, Communication, and Implementation. Translating innovation to successful implementation is crucially important and requires high-quality evidence to ensure steps forward to a positive impact on health care when it comes to implementation. The vision of EGS is to provide the best possible well-being and minimal glaucomainduced visual disability in individuals with glaucoma within an affordable healthcare system. In this regard, assessing the changes in glaucoma surgery is a pivotal contribution to better care. As mentioned, this Guide aims to provide answers to the crucial questions above. However, every clinician is aware that answers may differ for every person: an individualised approach is needed. Therefore, there will be no uniform answer for all situations and all patients. Clinicians would need, through the clinical method and possibly some algorithm, to reach answers and decisions at the individual level. In this regard, evidence is needed to support clinicians to make decisions. Of key importance in this Guide is to provide an overview of existing evidence on glaucoma surgery and specifically on recent innovations and novel devices, but also to set standards in surgical design and reporting for future studies on glaucoma surgical innovation. Designing studies in surgery is particularly challenging because of many subtle variations inherent to surgery and hence multiple factors involved in the outcome, but even more because one needs to define carefully outcomes relevant to the research question but also to the future translation into clinical practice. In addition this Guide aims to provide clinical recommendations on novel procedures already in use when insufficient evidence exists. EGS has a long tradition to provide guidance to the ophthalmic community in Europe and worldwide through the EGS Guidelines (now in their 5th Edition). The EGS leadership recognized that the changing environment in glaucoma surgery currently represents a major challenge for the clinician, needing specific guidance. Therefore, the decision was made to issue this Guide on Glaucoma Surgery in order to help clinicians to make appropriate decisions for their patients and also to provide the framework and guidance for researchers to improve the quality of evidence in future studies. Ultimately this Guide will support better Glaucoma Care in accordance with EGS's Vision and Mission. Fotis Topouzis EGS President

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Abegao Pinto L, Sunaric Mégevand G, Stalmans I, et al. European Glaucoma Society - A guide on surgical innovation for glaucoma. Br J Ophthalmol. 2023. PMID: 38128960. doi:10.1136/bjophthalmol-2023-egsguidelines

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。